Express Pharma

300 per cent increase in companies conducting endometriosis clinical trials since 2010: GlobalData

Bayer, Ferring International and AbbVie were among the most highly active sponsors with 21, 11 and seven trials, respectively

0 294

According to GlobalData’s clinical trial database, the landscape for endometriosis has greatly diversified in recent years. The number of companies initiating trials in the space rose from only three in 2010 to 12 in 2019 – an increase of 300 per cent over the ten-year period.

Fiona Chisholm, Pharma Analyst at GlobalData comments, “The endometriosis market is increasingly becoming more attractive to drug developers, as understanding and awareness of the disease increases. Patients are also becoming more empowered to proactively manage their menstrual health. The trend towards an increasingly diverse clinical trials landscape coincides with an explosion in the usage of ‘femtech’ products such as period-tracking apps, as well as advertising and